Close



Feb 22, 2023 07:30AM
Feb 22, 2023 07:30AM
Mar 3, 2022 07:37AM
Mar 3, 2022 07:30AM
Oct 19, 2021 09:00AM
Oct 19, 2021 09:00AM
Jul 27, 2021 08:00AM Entasis Therapeutics and Zai Lab Complete Patient Enrollment in the ATTACK Phase 3 Registrational Clinical Trial of Sulbactam-Durlobactam
Apr 28, 2021 06:23AM
Apr 13, 2021 09:19AM
Sep 1, 2020 04:05PM
Aug 17, 2020 07:30AM
Aug 17, 2020 07:30AM
Aug 3, 2020 04:05PM
Jul 19, 2020 08:00PM Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization
Jul 19, 2020 07:05PM
Jul 7, 2020 07:35AM
Jul 7, 2020 07:30AM
Jul 7, 2020 07:30AM
Jul 7, 2020 07:30AM
Jul 7, 2020 07:30AM
Feb 27, 2020 04:05PM Five Prime Therapeutics Reports Fourth Quarter and Full Year 2019 Results
Jan 14, 2020 07:31AM
Jan 14, 2020 07:30AM
Jan 14, 2020 07:30AM
Oct 1, 2019 04:30PM
Aug 1, 2019 04:05PM
Mar 1, 2019 04:30PM
Mar 30, 2018 08:00AM Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Mar 1, 2018 04:05PM
Feb 1, 2018 04:01PM
Dec 1, 2017 04:01PM
Nov 1, 2017 04:01PM
Oct 2, 2017 04:01PM

923,755 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All